Publications by Residents

Nguyen AT, Luu M, Mallen-St. Clair J, Mita A, Scher K, Lu DJ, Shiao SL, Ho AS, Zumsteg ZS. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell Carcinoma.  JAMA Oncol. Published online August 20, 2020. 

Anderson EM, David J, Phillips T, DemarcoJ, Reznik RS, Mirhadi AJ, Kamrava M. Interstitial high-dose-rate brachytherapy in the treatment of keloids: Moving toward a volumetric approach. Brachytherapy. 2020;S1538-4721(20)30145-8. Advance online publication.

Lu DJ, Luu M, Nguyen AT, Shiao SL, Scher K, Mita A, Anderson E, Mallen-St. Clair J, Ho AS, Zumsteg ZS, et al. The role of concomitant chemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era. Oral Oncology. [published online ahead of print, 2020 Jul 7]. 

Tam M, Luu M, Barker CA, Lu DJ, Ho AS, Zumsteg ZS. Improved survival in women versus men with merkel cell carcinoma. J Am Acad Dermatol. 2020 May 15;S0190-9622(20)30273-5.

Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen A, Shiao SL, Young K. Effects of Radiation on the Tumor Microenvironment. Semin Radiat Oncol. 2020;30(2):145-157.

Tuli R, David J, Lobaugh S, Zhang Z, O'Reilly EM. Duration of therapy for locally advanced pancreatic cancer: Does it matter? Cancer Med. 2020 Jul;9(13):4572-4580. PMID: 32368871; PMCID: PMC7333837.

Gartland RM, Myers LC, Iorgulescu JB, Nguyen AT, Yu-Moe CW, Falcone B, Mitchell R, Kachalia A, Mort E. Body of Evidence. Do Autopsy Findings Impact Medical Malpractice Claim Outcomes? Journal of Patient Safety. 2020 March 23.

Lu DJ, Phillips T, DeMarco J, Sandler HM, Kamrava M. A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy. Brachytherapy. 2020;19(2):216-221.

Nguyen AT, Luu M, Lu DJ, Hamid O, Mallen-St Clair J, Faries MB, Gharavi NM, Ho AS, Zumsteg ZS. Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma. J Am Acad Dermatol. 2020;S0190-9622(20)30062-1.

Lu DJ, Luu M, Nguyen AT, Scher KS, Clair JM, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncology. 2019;99, 104472.

Sittig MP, Luu M, Yoshida EJ, Scher K, Mita A, Shiao SL, Lu DJ, Mallen-St Clair J, Ho AS, Zumsteg ZS. Impact of insurance on survival in patients < 65 with head and neck cancer treated with radiotherapy [published online ahead of print October 29, 2019]. Clin Otolaryngol. 2019 Oct 29.

Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Nguyen AT, Shiao SL, Ho AS, Zumsteg ZS. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? [published online ahead of print September 19, 2019]. Cancer. 2019 Sep 19.

Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Yoshida EJ, Mallen-St Clair J, Shiao SL, Leivo I, Zumsteg ZS. Survival impact of adjuvant therapy in salivary gland cancers following resection and neck dissection. Otolaryngol Head Neck Surg. 2019 Jun;160(6):1048-1057.

Lu DJ, Luu M, Nguyen AT, Scher KS, Clair JM, Mita A, Shiao SL, Ho AS, Zumsteg ZS. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncol. 2019 Nov 5;99:104472.

Lu DJ, Luu M, Yashar CM, Klopp AH, Kamrava M. An evaluation of gender diversity in the American Brachytherapy Society. Brachytherapy. 2019 Nov-Dec;18(6):835-840.

Zumsteg ZS, Luu M, Kim S, Tighiouart M, Mita A, Scher KS, Lu DJ, Shiao SL, Mallen-St Clair J, Ho AS. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann Oncol. 2019 Oct 1;30(10):1669.

David JM, Yue Y, Blas K, Hendifar A, Kabolizadeh P, Tuli R. 18F-FDG PET predicts hematologic toxicity in patients with locally advanced anal cancer treated with chemoradiation. Adv Radiat Oncol. 2019 Oct-Dec;4(4):613-622.

Guan M, He I, Luu M, David J, Gong J, Placencio-Hickok VR, Reznik RS, Tuli R, Hendifar AE. Palliative radiation therapy for bone metastases in neuroendocrine neoplasms. Adv Radiat Oncol. 2019 Jul-Dec;4(3):513-519.

Toll SA, Jones MT, Yoshida EJ, Dhall G, Olch AJ, Wong KK. The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. Pediatr Blood Cancer. 2019 Dec;66(12):e28005.

Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma. HPB (Oxford). 2019 Jul;21(7):849-856.

Lu DJ, Luu M, Mita A, Scher K, Shiao SL, Yoshida EP, Sittig MP, Mallen-St Clair J, Ho AS, Zumsteg ZS. Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications. Eur J Cancer. 2018 Nov;103:195-204.

Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Clair JM, Yoshida EJ, Shiao SL, Leivo I, Zumsteg ZS. Development of a novel salivary gland cancer lymph node staging system. Cancer. 2018 Aug 1;124(15):3171-3180.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Ho AS, Zumsteg ZS. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification. Head Neck. 2018 Jun;40(6):1228-1236.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Lee NY, Ho AS, Zumsteg ZS. Facility volume and survival in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):408-417.

Ohri N, Sittig MP, Tsai CJ, Hwang ES, Mittendorf EA, Shi W, Zhang Z, Ho AY. Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis. Cancer. 2018 Feb 1;124(3):482-490.

David JM, Kim S, Placencio-Hickok VR, Torosian A, Hendifar A, Tuli R. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Adv Radiat Oncol. 2018 Nov 9;4(2):302-313.

Lao Y, David J, Mirhadi A, Lepore N, Sandler H, Wang Y, Tuli R, Yang W. Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changes. Phys Med Biol. 2018 Nov 7;63(21):215027.

David JM, Gresham G, Jabbour SK, Deek M, Thomassian S, Robertson JM, Newman NB, Herman JM, Osipov A, Kabolizadeh P, Tuli R. Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer. J Gastrointest Oncol. 2018 Aug;9(4):641-649.

Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. Patient and Facility Demographics related outcomes in early-stage non-small cell lung cancer treated with radiofrequency ablation: A National Cancer Database Analysis. J Vasc Interv Radiol. 2018 Nov;29(11):1535-1541.e2.

Lam A, Yoshida EJ, Bui K, Fernando D, Nelson K, Abi-Jaoudeh N. A National Cancer Database Analysis of radiofrequency ablation versus stereotactic body radiotherapy in early-stage non-small cell lung cancer. J Vasc Interv Radiol. 2018 Sep;29(9):1211-1217.e1.